当前位置：首页 > 文献互助 > 互助详情

Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors复制

用户6X7Ch8WUQ_gI 11小时前 6 10 求助中 帖子自动结束时间: 2025-06-20 11:08:08

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.ejmech.2025.117845复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0223523425006105复制

其他信息:

出版社: Elsevier BV
作者: Haibin Yuan; Yue Gao; Peipei Wang; Xiaowu Dong; Jia Li; Chenxi Wang; Jinxin Che; Yubo Zhou; Tao Liu

上一篇：Rational Design of CZL-S092: A Novel Indazole-Based PLK4 Inhibitor Targeting Neuroblastoma through Virtual Screening and Fragment-Based Drug Design Strategies

下一篇：Discovery and optimization of novel tetrahydrothiazolopyridine-based pyrimidines as highly potent cyclin-dependent kinase 9 (CDK9) inhibitors

互助时间线

2025-06-15 11:08:08 [发起求助]

最新发布的求助

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors 3小时前
CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity 3小时前
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study 6小时前
Decade trends in risk factors, treatments, and prognosis of minor ischemic stroke and tia in china 6小时前
Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel 7小时前
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study 7小时前
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors 10小时前
Knowledge, Attitudes, and Practices Regarding Meningococcal B Vaccination Since the 2015 Recommendation: A Review 11小时前
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates 11小时前
Discovery and optimization of novel tetrahydrothiazolopyridine-based pyrimidines as highly potent cyclin-dependent kinase 9 (CDK9) inhibitors 11小时前
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors 11小时前
Rational Design of CZL-S092: A Novel Indazole-Based PLK4 Inhibitor Targeting Neuroblastoma through Virtual Screening and Fragment-Based Drug Design Strategies 11小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com